Benelux Price Negotiations: Beware of EU-Wide Pricing Policy, warns Germany

Manufacturers could find themselves talking with multiple EU member states at once to get their orphan drugs to patients if a pilot on joint pricing negotiations is a success. Currently Belgium, the Netherlands and Luxemburg are developing the pilot, but more countries are looking at whether they may want to join in.